Search
Factsheet about seasonal influenza
Influenza is a contagious respiratory illness caused by influenza viruses that infect the nose, throat, and sometimes the lungs. It can cause mild to severe illness, and at times can lead to death. The best way to prevent flu is by getting a flu vaccine each year.
Risk groups for severe influenza
Some people are at high risk of serious complications as a result of influenza, some of which can be life-threatening and result in death. The risk groups includes people who are more likely than others to develop severe disease if they should be infected, such as the elderly, pregnant women, young children and people with underlying health conditions.
External Link
European Medicines Agency: Treatments and vaccines for COVID-19
The European Medicines Agency (EMA) is interacting with developers of potential COVID-19 treatments and vaccines to enable promising medicines to reach patients as soon as possible. It is also making use of real-world data to monitor the safety and effectiveness of medicines used in patients with COVID-19.
External Link
Vaccination Portal : COVID-19 vaccines
Information about COVID-19 vaccines and vaccine development
External Link
Video of the European Council: COVID-19 vaccines: Why so fast?
Watch and find out why COVID-19 vaccines are being fast-tracked, without compromising quality, safety and efficacy.
News
Monitoring COVID-19 vaccination progress across Europe
Following the conditional marketing authorisation and deployment of the first COVID-19 vaccines in the EU/EEA, all countries have started vaccination campaigns by vaccinating people in priority groups. To monitor the progress of vaccination efforts across the EU/EEA, ECDC has set up a monitoring system for collection of key vaccine rollout indicators.
Publication
Interim technical guidance on public health use of influenza antivirals during influenza pandemics
Antiviral drugs are an important addition to the public health arsenal against influenza. This interim guidance discusses the options for their effective use, especially during a pandemic.
Publication
Interim technical guidance on use of specific pandemic influenza vaccines during the H1N1 2009 pandemic
This interim guidance outlines the possible strategies that countries may wish to adopt in the deployment of a pandemic-specific vaccine, considering the two objectives of vaccination: protecting those at greatest risk of severe disease and maintaining essential services.
External Link
Preparedness for COVID-19 vaccination strategies and vaccine deployment
Communication from the Commission to the European Parliament and the Council